Wellgistics Health, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
DataMeds AI, Inc. (formerly Wellgistics Health, Inc.) reported a significant decrease in net revenues for the first six months of 2026 compared to the prior year, primarily due to liquidity constraints impacting its distribution business, alongside a substantial net loss.
NASDAQ
Wellgistics Health, Inc. reported a significant net loss of $34.3 million for Q3 2025 and $73.4 million year-to-date, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
Wellgistics Health, Inc. reported a dramatic increase in net loss to $39.1 million for the first half of 2025, raising substantial doubt about its ability to continue as a going concern, despite significant revenue growth from recent acquisitions.
NASDAQ
Wellgistics Health's Q1 2025 results reflect the impact of recent acquisitions, with net sales reaching $10.9 million but a significant net loss reported.